Accession Number: | 0001209191-22-037480 |
Date: | 2022-06-15 |
Issuer: | SQZ BIOTECHNOLOGIES CO (SQZ) |
Original Submission Date: |
SRIVASTAVA SAPNA
200 ARSENAL YARDS BLVD, SUITE 210
WATERTOWN, MA 02472
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 3.23 | 2022-06-15 | deemed execution date | A | 20,000 (a) | 2032-06-14 | common stock 20,000 | $3.23 | 20,000 | direct |
ID | footnote |
---|---|
f1 | the option vests and become exercisable on the earlier of (i) june 15, 2023 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the board at such time. |